Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
Inv. presentation
Employment agrmnt
Director departure
Appointed director
UNIGENE LABORATORIES INC (UGNE) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/02/2013 8-K Resignation/termination of a director
06/17/2013 8-K Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financia...
Docs: "Senior Secured Convertible Note, reissued by the Company as of June 11, 2013 in favor of Victory Park Credit Opportunities Intermediate Fund, L.P",
"Senior Secured Convertible Note, reissued by the Company as of June 11, 2013 in favor of Victory Park Credit Opportunities, L.P",
"Senior Secured Convertible Note, reissued by the Company as of June 11, 2013 in favor of VPC Intermediate Fund II (Cayman), L.P",
"Senior Secured Convertible Note, reissued by the Company as of June 11, 2013 in favor of VPC Fund II, L.P"
06/13/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
06/13/2013 SC 13D/A Victory Park Capital Advisors, LLC reports a 65.4% stake in UNIGENE LABORATORIES, INC.
06/07/2013 8-K Quarterly results
06/05/2013 4 Victory Park Capital Advisors, LLC (10% Owner) has filed a Form 4 on UNIGENE LABORATORIES INC
Txns: Granted options to buy @ $0
05/29/2013 8-K Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arran...
05/24/2013 SC 13D/A Victory Park Capital Advisors, LLC reports a 65.4% stake in UNIGENE LABORATORIES, INC.
05/16/2013 4 Victory Park Capital Advisors, LLC (10% Owner) has filed a Form 4 on UNIGENE LABORATORIES INC
Txns: Disposed/sold 351,166 options to buy @ $0
Disposed/sold 310,239 options to buy @ $0
Disposed/sold 154,472 options to buy @ $0
Disposed/sold 184,122 options to buy @ $0
Granted 500,000 options to buy @ $0
05/14/2013 10-Q Quarterly Report for the period ended March 31, 2013
05/03/2013 4 Levy Richard N (10% Owner) has filed a Form 4 on UNIGENE LABORATORIES INC
Txns: Granted 75,000 options to buy @ $0.0354, valued at $2.7k
05/03/2013 4 Tune Joel A. (Director) has filed a Form 4 on UNIGENE LABORATORIES INC
Txns: Granted 10,000 shares @ $0
Granted 20,000 options to buy @ $0.0354, valued at $708
05/03/2013 4 SABATINO THOMAS J JR (Director) has filed a Form 4 on UNIGENE LABORATORIES INC
Txns: Granted 10,000 shares @ $0
Granted 20,000 options @ $0.0354, valued at $708
05/03/2013 4 Odlaug Theron Edwin (Director) has filed a Form 4 on UNIGENE LABORATORIES INC
Txns: Granted 10,000 shares @ $0
Granted 20,000 options @ $0.0354, valued at $708
05/03/2013 4 WYSZOMIERSKI JACK L (Director) has filed a Form 4 on UNIGENE LABORATORIES INC
Txns: Granted 10,000 shares @ $0
Granted 20,000 options @ $0.0354, valued at $708
05/02/2013 SC 13D/A Victory Park Capital Advisors, LLC reports a 65.4% stake in UNIGENE LABORATORIES, INC.
04/30/2013 10-K/A Annual Report for the period ended December 31, 2012 [amend]
04/29/2013 4 Victory Park Capital Advisors, LLC (10% Owner) has filed a Form 4 on UNIGENE LABORATORIES INC
Txns: Disposed/sold 4,618,181 options to buy @ $0
Disposed/sold 4,079,950 options to buy @ $0
Disposed/sold 3,880,485 options to buy @ $0
Disposed/sold 2,421,384 options to buy @ $0
04/22/2013 D Form D - Notice of Exempt Offering of Securities
04/16/2013 8-K Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits
Docs: "Letter of Concurrence from Grant Thornton LLP Regarding Change in Certifying Accountant"
04/12/2013 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
04/12/2013 8-K Form 8-K - Current report
04/10/2013 4 Victory Park Capital Advisors, LLC (10% Owner) has filed a Form 4 on UNIGENE LABORATORIES INC
Txns: Granted options to buy @ $0
03/15/2013 10-K Annual Report for the period ended December 31, 2012
03/12/2013 8-K Quarterly results
Docs: "UNIGENE LABORATORIES, INC. BALANCE SHEETS DECEMBER 31, 2012 and 2011 2012 2011 ASSETS Current Assets: Cash and cash equivalents $ 3,813,492 $ 4,681,683 Accounts receivable 76,255 2,854,038 Accounts receivable - Tarsa -- 8,193 Inventory, net 898,042 1,283,550 Due from former China joint venture partner -- 600,000 Prepaid expenses and other current assets 848,573 862,761 Total Current Assets 5,636,362 10,290,225 Noncurrent inventory, net 1,063,633 1,946,647 Property, plant and equipment, net 2,651,819 2,977,058 Patents and other intangibles, net 1,920,574 2,020,458 Deferred financing costs, net -- 619,767 Other assets 40,513 341,014 Total Assets $ 11,312,901 $ 18,195,169 LIABILITIES AND STOCKHOLDERS' DEFICIT Current Liabilities: Accounts payable $ 731,359 $ 1,472,925 Accrued expenses 2,244,8..."
03/06/2013 8-K Other Events, Financial Statements and Exhibits
Docs: "Source: Unigene Laboratories, Inc."
01/31/2013 10-Q Quarterly Report for the period ended September 30, 2012
01/31/2013 10-Q/A Quarterly Report for the period ended June 30, 2012 [amend]
01/31/2013 10-Q/A Quarterly Report for the period ended March 31, 2012 [amend]
01/31/2013 10-K/A Annual Report for the period ended December 31, 2011 [amend]
01/04/2013 4 Tune Joel A. (Director) has filed a Form 4 on UNIGENE LABORATORIES INC
Txns: Granted 123,077 shares @ $0.13, valued at $16k
01/04/2013 4 SABATINO THOMAS J JR (Director) has filed a Form 4 on UNIGENE LABORATORIES INC
Txns: Granted 69,231 shares @ $0.13, valued at $9k
01/04/2013 4 Odlaug Theron Edwin (Director) has filed a Form 4 on UNIGENE LABORATORIES INC
Txns: Granted 92,308 shares @ $0.13, valued at $12k
01/04/2013 4 WYSZOMIERSKI JACK L (Director) has filed a Form 4 on UNIGENE LABORATORIES INC
Txns: Granted 107,692 shares @ $0.13, valued at $14k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy